Table 2 Clinical course before and after oral semaglutide administration
From: Oral semaglutide in kidney transplant recipients with metabolic syndrome: three Japanese cases
Case 1 | Case 2 | Case 3 | |
|---|---|---|---|
Body weight (Kg) | 100.6/96.3 | 75.4/63.2 | 79.1/76.4 |
BMI (Kg/m2) | 35.6/34.1 | 25.0/20.9 | 29.3/28.5 |
Abdominal circumference (cm) | 114/110 | 91/80 | 102/99 |
SBP (mmHg) | 128/121 | 140/133 | 124/128 |
DBP (mmHg) | 87/72 | 72/93 | 58/63 |
Cr (mg/dL) | 1.63/1.45 | 2.40/2.24 | 1.63/1.87 |
eGFR (ml/min/1.732) | 36.6/41.3 | 22.8/24.4 | 35.2/30.2 |
UA (mg/dL) | 4.8/4.9 | 4.1/3.2 | 3.6/3.8 |
ALT (IU/L) | 30/18 | 8/6 | 18/26 |
γ-GTP (IU/L) | 35/29 | 50/19 | 27/31 |
TG (mg/dL) | 154/201 | 308/227 | 205/123 |
HbA1c (%) | 5.9/5.6 | N.A GA(%) 14.5/13.0 | 5.5/5.6 |
UACR (mg/gCr) | 73.4/62.0 | N.A UPCR (g/gCr) 1.82/0.89 | 21.5/36.3 |
Observation period (months) | 12 | 12 | 12 |